Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Cagrilintide for Sale > Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - large image1
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image1
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image2
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image3
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image4
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image5
Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image6

Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10

TDS 66 Inquiries

Unit Price:

$90-110/UNIT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

any

Brand:

TNJONE

Packaging:

10vials/box: 5mg-30mg Bag: 0.1g, 1g, 10g, 100g, 1kg, 5kg,10kg

Sample Available:

Yes

Price valid (until):

2026-11-09

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
5 days
Qualification:
Main Products:

Semaglutide,Tirzepatide,API,Vitamins,Food Additive

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10


    Contact Information:
    Whatsapp :+86-18092446649
    Email :sarah@tnjone.com


    Description:

      • Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. Amylin, released with insu from beta cells in the pancreas, induces its satiating effect via both the homoeostatic and hedonic regions of the brain. Semaglutide, a GLP-1 receptor agonist, reduces appetite via GLP-1 receptors in the hypothalamus and increases the production of insu, and reduces glucagon secretion, delaying gastric emptying. These separate, but related mechanisms of action of an amylin-analog and a GLP-1 receptor agonist appear to have an additive effect on appetite reduction. Given the heterogeneity and complex pathogenesis of obesity, combination therapy with multiple pathophysiological targets is a logical approach to increasing weight loss response with pharmacotherapy. Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.
    Product Name Cagrilintide
    Cas No. 1415456-99-3
    MF C194H312N54O59S2
    Appearance White powder
    Customized Customized
    Shelf Life 2 Years When Properly Stored
    Storage Keep in a cool, dry, dark location in a tightly sealed container or cylinder.


    Appearance: Powder

    Purity: >99% (or refer to the Certificate of Analysis)

    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

    Solubility: To be determined

    Shelf Life: >2 years if stored properly

    Drug Formulation: To be determined

    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

    HS Tariff Code: 2934.99.9001

    Application: FOR WEIGHT LOSS


    Shop Tirzepatide 5mg 10mg 15mg 30mg Over Filled GLP1 customize Lyophilized powder-Detailed Image 1

    Shop Buying Thymosin Beta  Vials Thymosin B4 Acetate Peptide Thymosin β4 Acetate Tb5 Powder-Detailed Image 2

    Other hot selling products:


    Semaglutide is a new generation GLP-1 (glucagon-like peptide-1) analogues. Semaglutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

    Molecular Weight: 4813.45

    Appearance: White Powder

    Purity (HPLC): ≥99.0%

    Single Impurity (HPLC): ≤1.0%

    Moisture Content (Karl Fischer): ≤10.0%

    Peptide Content: ≥80.0%

    Storage: Store at -20℃ degrees Celsius in a dry and cool place.

    Storage Condition: Store at -20°C Solubility in DMSO: 3mg/mL (0.73 mM)


    SEMAGLUTIDE & TIRZEPATIDE


    GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide. 
    Tirzepatide is dosed at 5-15mg per week

    Semaglutide is dosed at 0.5-2.4mg per week

    Product Function:

    • Helps slow food leaving your stomach
    • Helps prevent your liver from making too much sugar
    • Helps the pancreas produce more insul when your blood sugar levels are high
    • Can help control blood glucose
    • Can reduce hyperglycemia, especially after meals
    • Can reduce fasting insul and fasting glucose
    • Can reduce hemoglobin A1c
    • Can decrease appetite and caloric intake, while inhibiting weight gain
    • Has been shown to lower triglyceride levels and oxidative stress from high LDL
    • Has been shown to help induce weight loss in obese patients with higher dosing
    • Helps decrease leptin and increase leptin sensitivity
    • Shop Buying Thymosin Beta  Vials Thymosin B4 Acetate Peptide Thymosin β4 Acetate Tb5 Powder-Detailed Image 3 Shop Buying Thymosin Beta  Vials Thymosin B4 Acetate Peptide Thymosin β4 Acetate Tb5 Powder-Detailed Image 4 Shop Buying Thymosin Beta  Vials Thymosin B4 Acetate Peptide Thymosin β4 Acetate Tb5 Powder-Detailed Image 5

    Company Information 
    Shop Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10-Detailed Image 6






    Shop Buying Thymosin Beta  Vials Thymosin B4 Acetate Peptide Thymosin β4 Acetate Tb5 Powder-Detailed Image 7 Shop Buying Thymosin Beta  Vials Thymosin B4 Acetate Peptide Thymosin β4 Acetate Tb5 Powder-Detailed Image 8
    Shop Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10-Detailed Image 9
    Shop Peptide CAS 1415456-99-3 Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10-Detailed Image 10
    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,API,Vitamins,Food Additive

    Location:

    No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New City, Xi 'an, Shaanxi Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    5 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2019

    Shaanxi TNJONE Pharmaceutical Technology Co., LTD., located in the beautiful ancient capital Xi 'an, is committed to the peptide industry, pharmaceutical raw materials, food and feed additives, veterinary drugs and other fields, the enterprise adhering to provide customers with quality service, supply high-quality products, "world peace and health" as its responsibility, the company adhering to the "meet all customer requirements for products" as the service concept, Guarantee "provide qualified products" as the service principle, so that you get "God-like" noble shopping enjoyment. Our company has more than 1000 kinds of polypeptides, raw materials inventory, at any time to meet the various needs of customers for products. Is your best partner.
  • Inquiry History
    66 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    20 MG Sep 30, 2026
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrilintide

    10 MG Sep 23, 2026
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.